Cargando…

Acute and late toxicity in prostate cancer patients treated by dose escalated intensity modulated radiation therapy and organ tracking

BACKGROUND: To report acute and late toxicity in prostate cancer patients treated by dose escalated intensity-modulated radiation therapy (IMRT) and organ tracking. METHODS: From 06/2004 to 12/2005 39 men were treated by 80 Gy IMRT along with organ tracking. Median age was 69 years, risk of recurren...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ghadjar, Pirus, Vock, Jacqueline, Vetterli, Daniel, Manser, Peter, Bigler, Roland, Tille, Jan, Madlung, Axel, Behrensmeier, Frank, Mini, Roberto, Aebersold, Daniel M
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2008
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2613141/ https://www.ncbi.nlm.nih.gov/pubmed/18937833 http://dx.doi.org/10.1186/1748-717X-3-35

Ejemplares similares

Late toxicity and five year outcomes after high-dose-rate brachytherapy as a monotherapy for localized prostate cancer
por: Ghadjar, Pirus, et al.
Publicado: (2014)

Prevention of radiochemotherapy-induced toxicity with amifostine in patients with malignant orbital tumors involving the lacrimal gland: a pilot study
por: Goldblum, David, et al.
Publicado: (2008)

Outcome and patterns of failure after postoperative intensity modulated radiotherapy for locally advanced or high-risk oral cavity squamous cell carcinoma
por: Geretschläger, Andreas, et al.
Publicado: (2012)

Postoperative Radiotherapy after Radical Prostatectomy: Indications and Open Questions
por: Ghadjar, Pirus, et al.
Publicado: (2012)

Clinically significant bleeding in incurable cancer patients: effectiveness of hemostatic radiotherapy
por: Cihoric, Nikola, et al.
Publicado: (2012)

Dose-escalated radiotherapy for unresectable or locally recurrent pancreatic cancer: Dose volume analysis, toxicity and outcome of 28 consecutive patients
por: Zschaeck, Sebastian, et al.
Publicado: (2017)

Role of Dose Intensification for Salvage Radiation Therapy after Radical Prostatectomy
por: Beck, Marcus, et al.
Publicado: (2016)

Regional hyperthermia and moderately dose-escalated salvage radiotherapy for recurrent prostate cancer. Protocol of a phase II trial
por: Müller, Arndt-Christian, et al.
Publicado: (2015)

Locally dose-escalated radiotherapy may improve intracranial local control and overall survival among patients with glioblastoma
por: Zschaeck, Sebastian, et al.
Publicado: (2018)

Modern radiation therapy and potential fertility preservation strategies in patients with cervical cancer undergoing chemoradiation
por: Ghadjar, Pirus, et al.
Publicado: (2015)

Definitive intensity modulated radiotherapy in locally advanced hypopharygeal and laryngeal squamous cell carcinoma: mature treatment results and patterns of locoregional failure
por: Geretschläger, Andreas, et al.
Publicado: (2015)

Tailored total lymphoid irradiation in heart transplant patients: 10-years experience of one center
por: Ghadjar, Pirus, et al.
Publicado: (2010)

Biological modelling of the radiation dose escalation effect of regional hyperthermia in cervical cancer
por: Crezee, J., et al.
Publicado: (2016)

Dose-Escalated Hypofractionated Intensity-Modulated Radiotherapy in High-Risk Carcinoma of the Prostate: Outcome and Late Toxicity
por: Thomson, David, et al.
Publicado: (2012)

Radiotherapy for Non-Hodgkin’s lymphoma: still standard practice and not an outdated treatment option
por: Zimmermann, Michel, et al.
Publicado: (2016)

Impact of weight loss on survival after chemoradiation for locally advanced head and neck Cancer: secondary results of a randomized phase III trial (SAKK 10/94)
por: Ghadjar, Pirus, et al.
Publicado: (2015)

Portfolio of prospective clinical trials including brachytherapy: an analysis of the ClinicalTrials.gov database
por: Cihoric, Nikola, et al.
Publicado: (2016)

Oncologic Thermoradiotherapy: Need for Evidence, Harmonisation, and Innovation
por: Bodis, Stephan, et al.
Publicado: (2022)

Moderately hypofractionated radiotherapy as definitive treatment for localized prostate cancer: Pattern of practice in German-speaking countries: A survey of the Prostate Cancer Expert Panel of the German Society of Radiation Oncology (DEGRO) and the Working Party on Radiation Oncology of the German Cancer Society (DKG-ARO)
por: Shelan, Mohamed, et al.
Publicado: (2021)

Dose escalated intensity modulated radiotherapy in the treatment of cervical cancer
por: Cihoric, Nikola, et al.
Publicado: (2015)

Treatment strategies to prevent and reduce gynecomastia and/or breast pain caused by antiandrogen therapy for prostate cancer: Statement from the DEGRO working group prostate cancer
por: Ghadjar, Pirus, et al.
Publicado: (2020)

Risk adapted dose-intensified postoperative radiation therapy in prostate cancer patients using a simultaneous integrated boost technique applied with helical Tomotherapy
por: Beck, Marcus, et al.
Publicado: (2017)

Toxicity of dose-escalated radiotherapy up to 84 Gy for prostate cancer
por: Rosenbrock, Johannes, et al.
Publicado: (2023)

Are contouring time and multimodality imaging prognostic factors for radiation therapy of advanced head and neck cancer?
por: Eller, Y, et al.
Publicado: (2015)

Prognostic indices in stereotactic radiotherapy of brain metastases of non-small cell lung cancer
por: Kaul, David, et al.
Publicado: (2015)

Regional hyperthermia combined with chemotherapy in paediatric, adolescent and young adult patients: current and future perspectives
por: Seifert, Georg, et al.
Publicado: (2016)

Are prognostic indices for brain metastases of melanoma still valid in the stereotactic era?
por: Badakhshi, Harun, et al.
Publicado: (2018)

Relation of baseline neutrophil-to-lymphocyte ratio to survival and toxicity in head and neck cancer patients treated with (chemo-) radiation
por: Bojaxhiu, Beat, et al.
Publicado: (2018)

External application of liver compresses to reduce fatigue in patients with metastatic cancer undergoing radiation therapy, a randomized clinical trial
por: Ghadjar, Pirus, et al.
Publicado: (2021)

Radiotherapy in nodal oligorecurrent prostate cancer
por: Pinkawa, Michael, et al.
Publicado: (2021)

Current status and perspectives of interventional clinical trials for glioblastoma – analysis of ClinicalTrials.gov
por: Cihoric, Nikola, et al.
Publicado: (2017)

Commentary on "Systematic review about complementary medical hyperthermia in oncology" by Liebl et al.
por: Arrojo, Elisabeth, et al.
Publicado: (2022)

Radiation treatment planning with embedded dose escalation
por: Hrinivich, William T., et al.
Publicado: (2019)

National trends in radiation dose escalation for glioblastoma
por: Wegner, Rodney E., et al.
Publicado: (2019)

Multimodal treatment for high-risk prostate cancer with high-dose intensity-modulated radiation therapy preceded or not by radical prostatectomy, concurrent intensified-dose docetaxel and long-term androgen deprivation therapy: results of a prospective phase II trial
por: Guttilla, Andrea, et al.
Publicado: (2014)

Randomized Pilot Trial Using External Yarrow Liver Compress Applications With Metastatic Cancer Patients Suffering From Fatigue: Evaluation of Sympathetic Modulation by Heart Rate Variability Analysis
por: Foucré, Clara, et al.
Publicado: (2022)

Intensity Modulated Radiation Therapy for Retroperitoneal Sarcoma: A Case for Dose Escalation and Organ at Risk Toxicity Reduction
por: Koshy, Mary, et al.
Publicado: (2003)

Salvage-Radiation Therapy and Regional Hyperthermia for Biochemically Recurrent Prostate Cancer after Radical Prostatectomy (Results of the Planned Interim Analysis)
por: Beck, Marcus, et al.
Publicado: (2021)

Accelerated hyperfractionation plus temozolomide in glioblastoma
por: Kaul, David, et al.
Publicado: (2016)

Patient-Specific Planning for Thermal Magnetic Resonance of Glioblastoma Multiforme
por: Oberacker, Eva, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_rtjbd9u8natr346qjj4hfeuqn9